Moteur de recherche d’entreprises européennes
Financement de l’UE (6 994 748 €) : Risk AssessmenT InnOvatioN for low-risk pesticides Hor14/10/2022 Programme de recherche et d'innovation de l'UE « Horizon »
Texte
Risk AssessmenT InnOvatioN for low-risk pesticides
Low risk pesticides (LRP) including (i) plant extracts (ii) semiochemicals like pheromones and allelochemicals, (iii) microbial pesticides, are gaining ground in the global market, as substitutes of synthetic pesticides. In addition, new microbial solutions (phages, protists, microbial consortia) and ds-RNA pesticides are emerging, low-risk solutions expect to reach the market in coming years. Despite on-going regulatory efforts by the European Commission, we are still lacking a concrete risk assessment (RA) scheme relevant to LRPs, a point which blocks LRPs reaching the EU market. RATION timely comes to address these regulatory constraints and aims to develop a novel RA scheme, supported by the necessary guidance on methods and tools, tailored to the specific characteristics of established and emerging LRP solutions. This main goal will be achieved through a series of interrelated WPs aiming (i) to map the current status of LRPs in Europe and identify main regulatory constraints (WP1). In this quest it will be supported by a stakeholders forum composed of all relevant actors (industry, regulators, academics, famers, general public); (ii) to develop and validate, through a proof-of-concept exercise, innovative RA (and associated tools) for microbials (WP2), plant extracts, semiochemicals, pheromones (WP3) and, ds-RNA (WP4); and from there (iii) build a harmonized RA for all LRP and determine its socioeconomic impact (WP5), (iv) to effectively communicate and disseminate the new RA knowledge and its associated tools developed by RATION to relevant actors ensuring sustainability beyond project duration (WP6). RATION will benchmark EU regulatory science, uplift blockers holding back LRP uptake by the EU market and motivate research innovation in plant protection. To achieve these goals 22 partners from academia, industry and regulatory bodies, representing 10 member states and 2 non-EU member states, will join forces in a multi-sectoral and multi-disciplinary effort.
| Genolution | ? |
| AEIFORIA HELLAS Ltd. | 194 688 € |
| Agencia Estatal Consejo Superior de Investigaciones Cientificas | 278 265 € |
| AIT Austrian Institute OF Technology GmbH | 499 571 € |
| BAYER AG | 7 500,00 € |
| Biobest Group N.V. | 141 875 € |
| CBC (Europe) Srl | 120 796 € |
| ECT OEKOTOXIKOLOGIE GmbH | 391 833 € |
| Ellinikos Georgikos Organismos - Dimitra | 197 188 € |
| Euroquality SAS | 233 750 € |
| HELMHOLTZ-ZENTRUM FUR UMWELTFORSCHUNG GmbH - UFZ | 407 625 € |
| Idryma Technologias Kai Erevnas | 266 500 € |
| Institut National de Recherche Pour l'Agriculture, l'Alimentation et l'Environnement | 207 725 € |
| Instytut Uprawy Nawozenia i Gleboznawstwa, Panstwowy Instytut Badawczy | 207 500 € |
| International Biocontrol Manufacturers Association | 75 000 € |
| JULIUS KUHN-INSTITUT BUNDESFORSCHUNGSINSTITUT FUR KULTURPFLANZEN | 452 838 € |
| METABOLIC INSIGHTS Ltd. | 700 250 € |
| Panepistimio Thessalias | 697 375 € |
| SYNGENTA AGRO GmbH | 152 500 € |
| Universite Catholique de Louvain | 373 750 € |
| WAGENINGEN UNIVERSITY | 1 192 346 € |
| WEIZMANN INSTITUTE OF SCIENCE | 195 875 € |
https://cordis.europa.eu/project/id/101084163
Cette annonce se réfère à une date antérieure et ne reflète pas nécessairement l’état actuel. L’état actuel est présenté à la page suivante : Genolution, 서울특별시, Corée du Sud.
